G
Giora Weisz
Researcher at Columbia University Medical Center
Publications - 298
Citations - 14101
Giora Weisz is an academic researcher from Columbia University Medical Center. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 50, co-authored 286 publications receiving 11524 citations. Previous affiliations of Giora Weisz include Columbia University & Duke University.
Papers
More filters
Journal ArticleDOI
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.
Guillermo J. Tearney,Evelyn Regar,Takashi Akasaka,Tom Adriaenssens,Peter Barlis,Hiram G. Bezerra,Brett E. Bouma,Nico Bruining,Jin-man Cho,Saqib Chowdhary,Marco A. Costa,Ranil de Silva,Jouke Dijkstra,Carlo Di Mario,Darius Dudeck,Erlin Falk,Marc D. Feldman,Peter J. Fitzgerald,Hector Garcia Garcia,Nieves Gonzalo,Juan F. Granada,Giulio Guagliumi,Niels Ramsing Holm,Yasuhiro Honda,Fumiaki Ikeno,Masanori Kawasaki,Janusz Kochman,Lukasz Koltowski,Takashi Kubo,Teruyoshi Kume,Hiroyuki Kyono,Cheung Chi Simon Lam,Guy Lamouche,David P. Lee,Martin B. Leon,Akiko Maehara,Olivia Manfrini,Gary S. Mintz,Kyiouchi Mizuno,Marie-Angèle Morel,Seemantini K. Nadkarni,Hiroyuki Okura,Hiromasa Otake,Arkadiusz Pietrasik,Francesco Prati,Lorenz Räber,Maria D. Radu,Johannes Rieber,Maria Riga,Andrew M. Rollins,Mireille Rosenberg,Vasile Sirbu,Patrick W. Serruys,Kenei Shimada,Toshiro Shinke,Junya Shite,Eliot Siegel,Shinjo Sonada,Melissa J. Suter,Shigeho Takarada,Atsushi Tanaka,Mitsuyasu Terashima,Thim Troels,Shiro Uemura,Giovanni J. Ughi,Heleen M.M. van Beusekom,Antonius F.W. van der Steen,Gerrit-Ann van Es,Gijs van Soest,Renu Virmani,Sergio Waxman,Neil J. Weissman,Giora Weisz +72 more
TL;DR: This document may be broadly used as a standard reference regarding the current state of theIVOCT imaging modality, intended for researchers and clinicians who use IVOCT and analyze IVO CT data.
Journal ArticleDOI
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone,Bernhard Witzenbichler,Giora Weisz,Michael Rinaldi,Franz-Josef Neumann,D. Christopher Metzger,Timothy D. Henry,David A. Cox,Peter L. Duffy,Ernest L. Mazzaferri,Paul A. Gurbel,Ke Xu,Helen Parise,Ajay J. Kirtane,Bruce R. Brodie,Roxana Mehran,Thomas Stuckey +16 more
TL;DR: The findings from this study emphasise the counter-balancing effects of haemorrhagic and ischaemic complications after stent implantation, and suggest that safer drugs or tailored strategies for the use of more potent agents must be developed if the benefits of greater platelet inhibition in patients with cardiovascular disease are to be realised.
Journal ArticleDOI
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study
Kenichi Fujii,Stephane Carlier,Gary S. Mintz,Yi-ming Yang,Issam Moussa,Giora Weisz,George Dangas,Roxana Mehran,Alexandra J. Lansky,Edward M. Kreps,Michael B. Collins,Gregg W. Stone,Jeffrey W. Moses,Martin B. Leon +13 more
TL;DR: In this article, the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation were determined. But, their results were limited to 15 patients who developed STC after successful SES implantation.
Journal ArticleDOI
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Roxana Mehran,Usman Baber,Samin K Sharma,David J. Cohen,Dominick J. Angiolillo,Carlo Briguori,Jin Y Cha,Timothy Collier,George Dangas,Dariusz Dudek,Vladimír Džavík,Javier Escaned,Robert J. Gil,Paul A. Gurbel,Christian W Hamm,Timothy D. Henry,Kurt Huber,Adnan Kastrati,Upendra Kaul,Ran Kornowski,Mitchell W. Krucoff,Vijay Kunadian,Steven O. Marx,Shamir R. Mehta,David J. Moliterno,E. Magnus Ohman,Keith G. Oldroyd,Gennaro Sardella,Samantha Sartori,Richard Shlofmitz,P. Gabriel Steg,Giora Weisz,Bernhard Witzenbichler,Yaling Han,Stuart J. Pocock,C. Michael Gibson +35 more
TL;DR: Among high-risk patients who underwent PCI and completed 3 months of dual antiplatelet therapy, ticagrelor monotherapy was associated with a lower incidence of clinically relevant bleeding than ticagerelor plus aspirin, with no higher risk of death, myocardial infarction, or stroke.
Journal ArticleDOI
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Roxana Mehran,Usman Baber,Philippe Gabriel Steg,Cono Ariti,Giora Weisz,Bernhard Witzenbichler,Timothy D. Henry,Annapoorna Kini,Thomas Stuckey,David J. Cohen,Peter B. Berger,Ioannis Iakovou,George Dangas,Ron Waksman,David Antoniucci,Samantha Sartori,Mitchell W. Krucoff,James B. Hermiller,Fayaz A. Shawl,C. Michael Gibson,Alaide Chieffo,Maria Alu,David J. Moliterno,Antonio Colombo,Stuart J. Pocock +24 more
TL;DR: This study enrolled 5031 patients undergoing PCI with stent implantation in 15 clinical sites in the USA and Europe between July 1, 2009, and Dec 2, 2010 and examined the effect of DAPT cessation on major adverse events (MACE) and found those who discontinued had lower MACE risk.